Department of Medical Research, 40293Taichung Veterans General Hospital, Taichung Veterans General Hospital, Taichung, Taiwan.
Department of Otolaryngology, 40293Taichung Veterans General Hospital, Taichung Veterans General Hospital, Taichung, Taiwan.
J Int Med Res. 2022 Jan;50(1):3000605211069281. doi: 10.1177/03000605211069281.
To evaluate the validity and test-retest reliability of the novel 'TIB' Olfactory Test Device (TIB) and to determine its normative values.
The study stratified the study subjects into normosmic, hyposmic and anosmic groups according to their olfactory function. The olfactory function of the subjects was evaluated using both the traditional Chinese version of the University of Pennsylvania of Smell Identification Test (UPSIT-TC) and the TIB. The normosmic group was used to retest with the UPSIT-TC and TIB at an inter-test interval of at least 7 days. The cut-off scores of TIB among the three different groups were determined by receiver operating characteristic curve analysis.
This study enrolled 180 subjects: 60 in each group. The mean scores of TIB were 44.1 for the normosmic group, 27.5 for the hyposmic group and 10.9 for the anosmic group. The TIB scores were significantly different across the three groups. There was a significant correlation between the first and second TIB tests ( = 0.506). The cut-off scores were 41 for normosmic subjects and 24 for hyposmic subjects.
The validity and test-retest reliability results suggest that the TIB is an appropriate olfactory test for the Taiwanese population.
评估新型“TIB”嗅觉测试装置(TIB)的有效性和重测信度,并确定其正常值。
根据嗅觉功能,将研究对象分为正常组、嗅觉减退组和嗅觉丧失组。使用传统的中文版宾夕法尼亚嗅觉识别测试(UPSIT-TC)和 TIB 评估受试者的嗅觉功能。正常组在至少 7 天的测试间隔后用 UPSIT-TC 和 TIB 进行复测。通过受试者工作特征曲线分析确定 TIB 在三组之间的截断分数。
本研究共纳入 180 名受试者:每组 60 名。正常组的 TIB 平均得分为 44.1,嗅觉减退组为 27.5,嗅觉丧失组为 10.9。三组 TIB 评分差异有统计学意义。TIB 第一次和第二次测试之间存在显著相关性(r=0.506)。正常组的截断分数为 41,嗅觉减退组为 24。
有效性和重测信度结果表明,TIB 是一种适合台湾人群的嗅觉测试。